Carlos von Bonhorst
Director/Board Member at EUROCINE VACCINES AB
Profile
Carlos von Bonhorst currently holds positions as a Board of Directors member at Eurocine Vaccines AB, a Consultant at Helsinn Healthcare SA, a Senior Advisor at Flerie Invest AB, a Reviewer at AAAS Fellowship Programs, Inc., and a Jury member at the European Innovation Council.
Previously, he served as a Member of the Board of Directors at Recipharm AB from 2015 to 2021, as a Director at Helsinn Healthcare SA from 1985 to 1993, as a Director at Laboratorios Biofarma SA from 1980 to 1985, and as a Scientific expert at the National Centre For Research & Development from 2017 to 2021.
Mr. Bonhorst earned a doctorate degree from the University of Lisbon in 1981.
Carlos von Bonhorst active positions
| Companies | Position | Start |
|---|---|---|
| EUROCINE VACCINES AB | Director/Board Member | 2022-11-30 |
Flerie Invest AB
 Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Consultant / Advisor | 2022-03-31 |
Helsinn Healthcare SA
 Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Consultant / Advisor | 2021-07-31 |
AAAS Fellowship Programs, Inc.
 AAAS Fellowship Programs, Inc. Insurance Brokers/ServicesFinance AAAS Fellowship Programs, Inc. provides health insurance services. The company is headquartered in Washington, DC. | Corporate Officer/Principal | 2015-04-30 |
| European Innovation Council | Corporate Officer/Principal | 2022-02-28 |
Former positions of Carlos von Bonhorst
| Companies | Position | End |
|---|---|---|
National Centre For Research & Development /Poland/
 National Centre For Research & Development /Poland/ Miscellaneous Commercial ServicesCommercial Services The National Centre for Research and Development in Poland provides executive agency services. | Corporate Officer/Principal | 2021-10-30 |
| RECIPHARM AB (PUBL) | Director/Board Member | 2021-03-30 |
Helsinn Healthcare SA /Venture/
 Helsinn Healthcare SA /Venture/ Investment ManagersFinance 3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg. | Private Equity Investor | 1993-12-30 |
| Laboratorios Biofarma SA | Sales & Marketing | 1985-12-30 |
Training of Carlos von Bonhorst
| University of Lisbon | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EUROCINE VACCINES AB | Health Technology |
| Private companies | 8 |
|---|---|
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Health Technology |
Recipharm AB
 Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Finance |
AAAS Fellowship Programs, Inc.
AAAS Fellowship Programs, Inc. Insurance Brokers/ServicesFinance AAAS Fellowship Programs, Inc. provides health insurance services. The company is headquartered in Washington, DC. | Finance |
Helsinn Healthcare SA /Venture/
Helsinn Healthcare SA /Venture/ Investment ManagersFinance 3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg. | Finance |
National Centre For Research & Development /Poland/
National Centre For Research & Development /Poland/ Miscellaneous Commercial ServicesCommercial Services The National Centre for Research and Development in Poland provides executive agency services. | Commercial Services |
| European Innovation Council | |
| Laboratorios Biofarma SA |
- Stock Market
- Insiders
- Carlos von Bonhorst